Phibro Animal Health reported $417.67M in Operating Expenses for its fiscal quarter ending in September of 2026.





Operating Expenses Change Date
Align Technology USD 821.72M 43.15M Sep/2026
ANI Pharmaceuticals USD 637.11M 39.9M Sep/2026
Aurora Cannabis CAD 76.28M 28.24M Jun/2026
Bristol-Myers Squibb USD 23.4B 1.08B Sep/2026
Canopy Growth CAD 98.74M 23K Jun/2026
Corcept Therapeutics USD 225.75M 10.9M Sep/2026
Eli Lilly USD 10.52B 496M Jun/2026
Henry Schein USD 3.27B 8M Sep/2026
Idexx Laboratories USD 811.89M 20.87M Sep/2026
Knight Therapeutics CAD 126.9M 8.29M Dec/2025
Merck USD 10.75B 5.02B Sep/2026
Nektar Therapeutics USD 49.12M 8.22M Mar/2026
Phibro Animal Health USD 417.67M 1.04B Sep/2026
Prestige Brands USD 213.19M 7.06M Jun/2026
Supernus Pharmaceuticals USD 1.06B 31.25M Sep/2026
Zoetis USD 3.3B 155M Sep/2026